Gregg L Semenza
President chez The Johns Hopkins University School of Medicine
Profil
Gregg L Semenza is the Director at the Institute For Cell Engineering.
He is also a Professor of Genetic Medicine at The Johns Hopkins University School of Medicine since 1990.
Additionally, he is a Venture Partner at Catalio Capital Management LP and an Advisor at Medical Excellence Capital LLC.
Semenza holds a doctorate degree from the University of Pennsylvania and an undergraduate degree from Harvard College.
Postes actifs de Gregg L Semenza
Sociétés | Poste | Début |
---|---|---|
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Private Equity Investor | - |
Medical Excellence Capital LLC
Medical Excellence Capital LLC Investment ManagersFinance Medical Excellence Capital LLC (MEC) is a venture capital firm founded in 2020 by John R. Prufeta. The firm is headquartered in New York City. | Consultant / Advisor | - |
The Johns Hopkins University School of Medicine | President | 01/01/1990 |
Institute For Cell Engineering | Directeur/Membre du Conseil | - |
Formation de Gregg L Semenza
University of Pennsylvania | Doctorate Degree |
Harvard College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 3 |
---|---|
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Finance |
Medical Excellence Capital LLC
Medical Excellence Capital LLC Investment ManagersFinance Medical Excellence Capital LLC (MEC) is a venture capital firm founded in 2020 by John R. Prufeta. The firm is headquartered in New York City. | Finance |
Institute For Cell Engineering |